Cited by 113Digital Radiography and Breast ImagingGlobal Cancer Incidence and ScreeningAI in cancer detection

Screening Mammography — A Long Run for a Short Slide?

Welch, H. Gilbert·2010·New England Journal of Medicine

Abstract

No screening test has ever been more carefully studied than screening mammography. In the past 50 years, more than 600,000 women have participated in 10 randomized trials, each involving approximately 10 years of follow-up. Given this extraordinary research effort, it is ironic that screening mammography continues to be one of the most contentious issues within the medical community.The juxtaposition of such a charged medical debate in the face of such an exhaustive scientific investigation is in itself instructive. For context, one trial involving fewer than 150 men who were followed for less than 2 years was sufficient to convince . . .

Integrity signals

Registry

Crossref · 10.1056/nejme1008369

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Welch, H. G.
Affiliations
Dartmouth Institute for Health Policy and Clinical Practice (US)
Corresponding author
Welch, H. Gilbert
Venue
New England Journal of Medicine
Published
2010-09-23
Volume
363
Issue
13
Pages
1276-1278
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2161145860
Cited by
113
References
9
Citations by year
2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 4 · 2015: 9 · 2014: 10 · 2013: 13 · 2012: 22
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Digital Radiography and Breast Imaging
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
mammography screening, breast cancer screening, randomized controlled trials, long-term follow-up, breast cancer mortality
MeSH terms
Breast Neoplasms, Europe, Female, Humans, Mammography, Mass Screening, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review